Concomitant teriparatide plus raloxifene for the treatment of postmenopausal osteoporosis: Results from a randomized placebo-controlled trial

被引：0
|
作者：
Krege, JH
Omizo, M
Schwartz, EN
Eriksen, EF
Cantor, P
Wang, J
Glass, EV
Myers, SL
Deal, C
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Oregon Osteoporosis Ctr, Portland, OR USA
[3] Fdn Osteoporosis Res & Educ, Oakland, CA USA
[4] Cleveland Clin Fdn, Ctr Osteoporosis & Metab Bone Dis, Cleveland, OH 44195 USA
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] Concomitant teriparatide plus raloxifene for the treatment of postmenopausal osteoporosis: Results from a randomized placebo-controlled trial
    Deal, C
    Omizo, M
    Schwartz, EN
    Eriksen, EF
    Cantor, P
    Wang, JY
    Glass, EV
    Myers, SL
    Krege, JH
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S670 - S670
  • [2] Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: Results from a 6-month double-blind placebo-controlled trial
    Deal, C
    Omizo, M
    Schwartz, EN
    Eriksen, EF
    Cantor, P
    Wang, JY
    Glass, EV
    Myers, SL
    Krege, JH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (11) : 1905 - 1911
  • [3] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
    Morii, H
    Ohashi, Y
    Taketani, Y
    Fukunaga, M
    Nakamura, T
    Itabashi, A
    Sarkar, S
    Harper, K
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (10) : 793 - 800
  • [4] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
    H. Morii
    Y. Ohashi
    Y. Taketani
    M. Fukunaga
    T. Nakamura
    A. Itabashi
    S. Sarkar
    K. Harper
    Osteoporosis International, 2003, 14 : 793 - 800
  • [5] Randomized placebo-controlled trial of brisk walking in the prevention of postmenopausal osteoporosis
    Ebrahim, S
    Thompson, PW
    Baskaran, V
    Evans, K
    AGE AND AGEING, 1997, 26 (04) : 253 - 260
  • [6] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Iniesta, Raquel
    Cobo, Jesus
    Araya, Susana
    Roca, Mercedes
    Serrano-Blanco, Antoni
    Teba, Fernando
    Ochoa, Susana
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1552 - 1557
  • [7] The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial
    Shand, B
    Gilchrist, N
    Blackwell, T
    March, R
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2002, 26 (04) : 249 - 255
  • [8] Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: A placebo-controlled randomized trial
    Strickler, R
    Stovall, DW
    Merritt, D
    Shen, W
    Wong, M
    Silfen, SL
    OBSTETRICS AND GYNECOLOGY, 2000, 96 (03): : 359 - 365
  • [9] Effect of raloxifene after teriparatide treatment in postmenopausal women with osteoporosis
    Adami, S.
    Munoz-Torres, M.
    Econs, M. J.
    Sipos, A.
    Xie, L.
    Dalsky, G. P.
    McClung, M.
    Felsenberg, D.
    Brown, J. P.
    Brandi, M. L.
    San Martin, J.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S137 - S137
  • [10] Teriparatide and Raloxifene Reduce the Risk of New Adjacent Vertebral Fractures in Postmenopausal Women with Osteoporosis Results from Two Randomized Controlled Trials
    Bouxsein, Mary L.
    Chen, Peiqi
    Glass, Emmett V.
    Kallmes, David F.
    Delmas, Pierre D.
    Mitlak, Bruce H.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (06): : 1329 - 1338
12345